One John Marshall Drive

Robert C. Byrd Biotechnology Science Center, Suite 314

Huntington, WV 25755

304-638-6500

info@progenesistechnologies.com

Management Advisory Board

 

Richard M. Niles, Ph.D. | Download CV

rniles@progenesistechnologies.com

Dr. Niles is COO and a founding member of Progenesis.  He is also an Emeritus Professor/Chair of the Department of Biochemistry and Microbiology at the Joan C Edwards School of Medicine, Marshall University, Huntington  W, where he also serve as Senior Associate Dean for Research and Graduate Education.  Dr. Niles has served on and chaired many grant review panels for the NIH, DoD Breast Cancer Research Program and Prostate Cancer Research Program, as well as the American Institute for Cancer Research, a private foundation that funds research on nutrition and cancer.  He is currently the Principal Investigator for Progenesis’ Phase I NIH SBIR award and for the pending Phase II NIH SBIR grant application.  Prior to assuming the Chair of Biochemistry position at Marshall in 1992, he was Professor of Biochemistry at Boston University School of Medicine.  His broad training and experience in Plant Pathology, Microbiology, Biochemistry/Polysaccharide Metabolism, together with his administrative experience, has helped to shape the strategic development plans for Progenesis.

 

Hongwei Yu, Ph.D. | Download CV

hyu@progenesistechnologies.com

Dr. Yu is Vice-President, Chief Science Officer and a founding member of Progenesis. He is also Professor of Biochemistry and Microbiology, Joan C. Edwards School of Medicine, Marshall University. He has an active research program to study the genetic regulation of bacterial biofilms and polysaccharide biosynthesis. More information about Dr. Yu’s research program can be found at Marshall Biomedical Sciences. Dr. Yu has received funding from NIH, NASA, Cystic Fibrosis Foundation and several Biotech companies. Dr. Yu and his former postdoctoral fellow, Dr. Qiu Dongree, have received a U.S. patent and EU patent and have a second pending patent on the use of Pseudomonas to produce alginate. Dr. Yu has authored 21 peer-reviewed papers in research journals. He received his B.Sc. degree in Aquaculture from Ocean University of China in 1983, M.Sc. in Microbiology from University of Alberta in 1990, Ph.D. in Molecular Pathogenesis from University of Calgary in 1994, followed by several years of postdoctoral training in Bacterial Molecular Genetics at the University of Michigan prior to coming to Marshall University.

 

Brandon Kirby, B.S.

bkirby@progenesistechnologies.com

Brandon is lead technician for Progenesis.  Brandon graduated from Bluefield State in May of 2015 with 4.0 GPA. From October 2011 to October 2015, he worked with Dr. Tesfaye Belay on experiments involving mouse models and molecular biology. He studied Pseudomonas aeruginosa biofilm development and worked on mouse infection models. He presented at many national conferences including Annual Biomedical Research Conference for Minority Students (ABRCMS) 2012, American Society for Microbiology (ASM) 2013, and National IDeA Symposium of Biomedical Research Excellence (NISBRE 2014). He was awarded a research and presentation award at ABRCMS in 2012 and a capstone award from ASM in 2013.

 

Advisory Board

 

Gardiner Smith - Executive Chair of the Board

smithgfh@progenesistech.com

Mr Smith has served in senior management roles in leading biopharmaceutical and life science start-up companies for over two decades.  He was CEO and President at AgeneBio and prior to that at TenxBiopharma.  He previously served as Senior Vice President of Business Development and Licensing at Aspreva Pharmaceuticals, where he had global responsibility for transactions with staff in the US, Canada and England.  Previous to this position, he was Chief Business Office at Memory Pharmaceuticals, helping to secure a number of corporate alliances and helping to take the company public in 2004.  He also held the position of Executive Director of Business Development at Human Genome Sciences and prior to this position was Director of International Licensing at GlaxoSmithKline. Mr. Smith began his career at Glaxo in 1987, moving through positions in chemistry, patents and transactional law.

 

Lake Polan III

Dr. Polan received her PhD and MD degrees from Yale University. She was Professor and Chair of the Department of Obstetrics and Gynecology at Stanford University School of Medicine until 2005. This was followed by several years as a Visiting Professor in the Department of Obstetrics and Gynecology at Columbia University School of Medicine. Presently Dr. Polan is Clinical Professor of Obstetrics, Gynecology and Reproductive Sciences at Yale University School of Medicine. She has a strong interest in biotechnology and women’s health. Dr. Polan was on the Board of Directors for Wyeth Pharmaceuticals until it was acquired by Pfizer in 2009.  She fostered the development of Quidel Corporation, a California-based diagnostic healthcare manufacturer, and is presently on its Board of Directors.

 

Mary Lake Polan, M.D., Ph.D.

Dr. Joseph I. Shapiro was born in Newark, NJ in 1954. He received a B.A. in Math from the University of Pennsylvania in 1976 and his M.D. from UMDNJ-Rutgers Medical School in 1980. Dr. Shapiro trained in Internal Medicine at Georgetown University Hospital (1980-83) and Nephrology at the University of Colorado (1983-87). He rose through the academic ranks there and moved to the University of Toledo (formerly the Medical College of Ohio) as Professor of Medicine and chief of Nephrology in 1997. He became chairman of Medicine in 1999, serving until 2012 when became Vice President and Dean of the School of Medicine at Marshall University. Dr. Shapiro has been active as a clinician, teacher and researcher. He has received a number of awards for his scholarship, teaching, research and institutional citizenship including induction into Alpha Omega Alpha, Fellowship in the American College of Physicians, American Society of Nephrology and American Heart Association and the Arnold P. Gold Humanism in Medicine Award.  Dr. Shapiro maintains board certification and has been listed on the various “top doctors” lists including Castle Connelly. During this career, Dr. Shapiro has received more than 40M dollars in funding from the NIH as principal or co-principal investigator and authored more than 250 scientific articles, book chapters and patents. Dr. Shapiro has also been active as an entrepreneur, starting several companies based on scientific discoveries.

 

John Maher, PhD

Vice President for Research Marshall University, Executive Director of the Marshall University Research Corporation

John is the Vice-President for Research at Marshall University and the Executive Director of the Marshall University Research Corporation. He oversees the operations which provide research and grant development, grant administration, research integrity oversight, compliance services and intellectual property management to Marshall University. Previously, he served as the Executive Director of the Chemical Alliance Zone, a regional economic development coalition, and worked for 21 years in research and development at Union Carbide Corporation, where he served in a broad range of technical and managerial assignments including catalysis research, plant technology support, intellectual property management, capital project execution and new business development. John received his A.B. at Cornell University and his Ph.D. in Organic/Organometallic Chemistry from Harvard University.

 

 

Joseph I. Shapiro, PhD

Dr. Joseph I. Shapiro was born in Newark, NJ in 1954. He received a B.A. in Math from the University of Pennsylvania in 1976 and his M.D. from UMDNJ-Rutgers Medical School in 1980. Dr. Shapiro trained in Internal Medicine at Georgetown University Hospital (1980-83) and Nephrology at the University of Colorado (1983-87). He rose through the academic ranks there and moved to the University of Toledo (formerly the Medical College of Ohio) as Professor of Medicine and chief of Nephrology in 1997. He became chairman of Medicine in 1999, serving until 2012 when became Vice President and Dean of the School of Medicine at Marshall University. Dr. Shapiro has been active as a clinician, teacher and researcher. He has received a number of awards for his scholarship, teaching, research and institutional citizenship including induction into Alpha Omega Alpha, Fellowship in the American College of Physicians, American Society of Nephrology and American Heart Association and the Arnold P. Gold Humanism in Medicine Award.  Dr. Shapiro maintains board certification and has been listed on the various “top doctors” lists including Castle Connelly. During this career, Dr. Shapiro has received more than 40M dollars in funding from the NIH as principal or co-principal investigator and authored more than 250 scientific articles, book chapters and patents. Dr. Shapiro has also been active as an entrepreneur, starting several companies based on scientific discoveries.

 

 

©2017 Progenesis Technologies

All Rights Reserved